We are proud to announce that Clinical Microbiomics is now officially present in the US – marked by the opening of our Boston Office at CIC (Kendall Square) on December 10th 2019.
Our Chief Business Officer, Jack Egelund, will be present at the official opening between the 10–13th of December.
We are ready to meet with US partners and collaborators in one of the greatest microbiome clusters in the world!
About Clinical Microbiomics
Clinical Microbiomics is a leading microbiome metagenomics service provider. We develop novel bioinformatics tools and integrative systems biology methods for state-of-the-art microbiome analysis. Our proprietary metagenomics platform provides our partners with leading capabilities for microbiome discovery and clinical research.
For further information, please contact:
Martin Santini, CEO: firstname.lastname@example.org, +45 5388 1254